PALMERI, SERENA
 Distribuzione geografica
Continente #
EU - Europa 890
AS - Asia 106
NA - Nord America 8
SA - Sud America 6
AF - Africa 1
Totale 1.011
Nazione #
IT - Italia 885
CN - Cina 38
SG - Singapore 34
VN - Vietnam 26
ID - Indonesia 5
BR - Brasile 4
MX - Messico 4
US - Stati Uniti d'America 4
CH - Svizzera 2
AR - Argentina 1
EC - Ecuador 1
GE - Georgia 1
HU - Ungheria 1
IE - Irlanda 1
JO - Giordania 1
KE - Kenya 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 1.011
Città #
Genoa 575
Vado Ligure 139
Genova 116
Rapallo 47
Beijing 11
Hanoi 8
Ho Chi Minh City 8
Tianjin 7
Singapore 5
Bordighera 4
Haiphong 4
Mexico City 4
Biên Hòa 2
Changsha 2
Lausanne 2
Amman 1
Angra dos Reis 1
Ashburn 1
Atibaia 1
Bandung 1
Boyolali 1
Budapest 1
Córdoba 1
Dublin 1
Guayaquil 1
Hangzhou 1
Karachi 1
Nairobi 1
Ninh Bình 1
Phoenix 1
Rio de Janeiro 1
San Jose 1
São José dos Pinhais 1
Tbilisi 1
Thái Bình 1
Thái Nguyên 1
Ulan-Ude 1
Totale 956
Nome #
Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report 132
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 106
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment 98
The short-chain fatty acid butyrate decreases the regulatory function of human natural killer cells and promotes their maturation 97
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study 93
Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF) 92
Pyrin Inflammasome Activation Defines Colchicine-Responsive SURF Patients from FMF and Other Recurrent Fevers 72
Mesenchymal stem cells for multiple sclerosis: effect of treatment on peripheral immune cells 68
Case Report: Multisystem inflammatory syndrome in children with associated proximal tubular injury 61
Corrigendum to “Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF)” Seminars in Arthritis and Rheumatism 55 (2022) 152024 (Seminars in Arthritis and Rheumatism (2022) 55, (S0049017222000750), (10.1016/j.semarthrit.2022.152024)) 58
An Update on Familial Mediterranean Fever 56
Baricitinib treatment in children with COPA syndrome 55
Efficacy of High-Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review 42
Predictive factors for therapeutic response and cluster analysis in syndrome of undifferentiated recurrent fever (SURF) 8
Long-term efficacy of MAS825, a bispecific anti-IL1β and IL-18 monoclonal antibody, in two patients with systemic JIA and recurrent episodes of macrophage activation syndrome 5
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib 3
Totale 1.046
Categoria #
all - tutte 3.977
article - articoli 3.977
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 1 2 1 2 3 2 1
2021/202239 2 0 0 2 0 6 0 8 3 5 2 11
2022/202357 4 5 0 7 10 5 2 4 6 2 11 1
2023/2024118 5 2 4 7 3 12 15 10 11 9 16 24
2024/2025410 28 25 24 23 37 34 38 86 9 17 53 36
2025/2026334 84 38 43 55 105 9 0 0 0 0 0 0
Totale 1.046